However, an accelerated form of diabetes was observed in BDC2.5 ICOS−/− transgenic NOD mice, indicating both that diabetogenic BDC2.5 effectors were ICOS-independent and that the ICOS/ICOSL interaction was central in the activation of regulatory T-cells. This evidence concerns the gene ICOS and diabetes mellitus.